Internal Server Error

Magellan BioScience Group - About the company

Magellan BioScience Group is an acquired company based in Tampa (United States), founded in 1997 by Todd Daviau and John M. Cronan. It operates as a Discovering novel therapeutics through unique microbial and peptide research libraries. Magellan BioScience Group has raised $25K in funding. The company has 39 active competitors, including 3 that have exited. Its top competitors include companies like C2 Pharma, AnalytiCon Discovery and Germe.

Company Details

Discovering novel therapeutics through unique microbial and peptide research libraries. The company offers diverse research libraries with unique compounds to study for potential therapeutic applications. These libraries provide access to the chemical diversity of natural products, enhancing prospects for novel discoveries in drug discovery research. They specialize in microbial strains, including microbial endophytic strains, and offer a synthetic peptide library for high-throughput screening or high-content screening microarray assays. The company seeks partners to develop novel applications for its peptide library. This is a B2B model focused on research and development, offering specialized libraries for pharmaceutical and biotechnology companies.
Social
XFacebook
Email ID
*****@magellanbioscience.com
Key Metrics
Founded Year
1997
Location
Stage
Acquired
Total Funding
$25K in 2 rounds
Investors
Ranked
Employee Count
8 as on Mar 31, 2026
Similar Companies
Exit Details
Acquired by Meridian Bioscience (Mar 24, 2016)

Magellan BioScience Group's acquisition details

Magellan BioScience Group got acquired by Meridian Bioscience on Mar 24, 2016 at an acquisition amount of $*****.
Click here to take a look at Magellan BioScience Group's acquisition in detail
Sign up to download Magellan BioScience Group's company profile

Magellan BioScience Group's funding and investors

Magellan BioScience Group has raised a total funding of $25K over 2 rounds. Its first funding round was on Jul 06, 2007. Magellan BioScience Group has 2 institutional investors.

Here is the list of recent funding rounds of Magellan BioScience Group:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Sep 17, 2012
3590546
Unattributed
1617879
4735915
4569912
3336277
Jul 06, 2007
9784101
Grant (prize money)
9627679
9590339
5573494
lockAccess funding benchmarks and valuations. Sign up today!

Magellan BioScience Group's founders and board of directors

Founder? Claim Profile
The founders of Magellan BioScience Group are Todd Daviau and John M. Cronan.
Here are the details of Magellan BioScience Group's key team members:

Magellan BioScience Group's employee count trend

Magellan BioScience Group has 8 employees as of Mar 26. Here is Magellan BioScience Group's employee count trend over the years:
Employee count trend for Magellan BioScience Group
lockUncover Magellan BioScience Group's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Magellan BioScience Group's Competitors and alternates

Top competitors of Magellan BioScience Group include C2 Pharma, AnalytiCon Discovery and Germe. Here is the list of Top 10 competitors of Magellan BioScience Group, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for C2 Pharma
C2 Pharma
2014, Luxembourg (Luxembourg), Unfunded
Offering APIs for the discovery and development of natural products
-
-
43/100
2nd
Logo for AnalytiCon Discovery
AnalytiCon Discovery
2000, Potsdam (Germany), Acquired
Specializes in natural products chemistry
$3.04M
41/100
3rd
Logo for Germe
Germe
1979, Marseille (France), Unfunded
Contract research, development and manufacturing for pharma, agri, food, and chemicals industries
-
-
27/100
4th
Logo for Metagreen
Metagreen
2015, Los Angeles (United States), Deadpooled
Develops technologies to harness the compounds of natural production
$12.1M
27/100
5th
Logo for Latoxan
Latoxan
1982, Portes les Valence (France), Unfunded
Venoms and toxins for drug discovery and high throughput screening applications
-
-
26/100
6th
Discovering novel therapeutics through unique microbial and peptide research libraries
$25K
28/100
7th
Logo for Bicoll
Bicoll
2000, Munich (Germany), Funding Raised
Preclinical services for drug discovery from natural products
-
24/100
8th
Logo for Kitoxan
Kitoxan
2006, Valence (France), Unfunded
Venom product library, a product of Latoxan, which is engaged in venom and toxin production
-
-
24/100
9th
Logo for Alfa Biotech
Alfa Biotech
2015, Hangzhou (China), Unfunded
Supplier of phytochemical standards and plant extracts
-
-
24/100
10th
Logo for Camasy Biotechnology
Camasy Biotechnology
2015, Jinan (China), Unfunded
Dietary supplements and pharmaceutical intermediates from natural products
-
-
24/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Magellan BioScience Group's competitors? Click here to see the top ones

Magellan BioScience Group's Investments and acquisitions

Magellan BioScience Group has made no investments or acquisitions yet.

News related to Magellan BioScience Group

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Magellan BioScience Group

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford